poisar

Stock

Sutro Biopharma, Inc. STRO

$21.23-0.56%

Overview

STRO market data

Price History

STRO price chart · 1M
O
21.06
H
21.66
L
21.06
C
21.23
Vol
6,881.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$21.06
Previous Close
$21.35
Day High
$21.66
Day Low
$21.06
52 Week High
$42.39
52 Week Low
$18.41
7 Day Return
+0.02%
30 Day Return
-10.44%
90 Day Return
-26.68%
1 Year Return
-40.23%
Daily Notional Volume
$146.1K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$22.49
Diluted earnings per share over the trailing twelve months.
Beta
1.47
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-154.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$7.15 – $43.85
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $360.1M · P/B 3.40 · P/S 3.61.

Company News

9 captured
Citizens Maintains Market Outperform on Sutro Biopharma, Lowers Price Target to $34Benzinga · Aug 13, 2026, 2:01 PM
Wedbush Reiterates Outperform on Sutro Biopharma, Maintains $60 Price TargetBenzinga · Aug 13, 2026, 12:54 PM
Why is Sutro Biopharma Stock Falling On Wednesday?Benzinga · Aug 12, 2026, 6:04 PM
Gold Gains 1%; Performance Food Group Shares Fall After Q4 ResultsBenzinga · Aug 12, 2026, 4:16 PM
Sutro Biopharma shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 12, 2026, 2:19 PM
8-K filing — SUTRO BIOPHARMA, INC. (STRO)SEC EDGAR · Aug 12, 2026, 11:15 AM
Sutro Biopharma Q2 EPS $(2.33) Misses $(2.19) Estimate, Sales $9.839M Miss $13.048M EstimateBenzinga · Aug 12, 2026, 11:02 AM
Truist Securities Assumes Sutro Biopharma at Buy, Announces Price Target of $50Benzinga · Jun 11, 2026, 12:46 PM
Barclays Initiates Coverage On Sutro Biopharma with Overweight Rating, Announces Price Target of $56Benzinga · May 28, 2026, 1:45 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock